Latest Ceo Transitions News

JB Hi-Fi Limited reported robust FY25 results with double-digit sales growth and a leadership transition, while outlining ambitious plans for FY26 focused on expansion and sustainability.

Perseus Mining reported steady gold production and cashflow growth in Q1 FY26, while progressing key projects including the CMA Underground and Nyanzaga development. The company also completed a CEO transition and renewed its share buyback program.

Vitrafy Life Sciences has delivered its first production unit of the next-generation cryopreservation device, advanced its US commercial footprint, and maintained a strong financial position heading into FY2026.

Region Group delivered solid financial results for FY25 with modest growth in funds from operations and assets under management, while announcing a planned CEO retirement and maintaining positive guidance for FY26.

Wellnex Life Limited announces the resignation of CEO Zack Bozinovski, who will remain with the company until April 2026, while a $2.3 million loan repayment schedule is negotiated.

AVITA Medical has appointed Board Chairman Cary Vance as Interim CEO following Jim Corbett's departure, while preliminary third-quarter revenue is expected to reach approximately $17 million.

Equinox Resources announces CEO Zac Komur will step down in November, with the Board launching a search for his successor amid ongoing development of the Hamersley iron ore project and strategic expansion plans.

Energy One Limited has appointed Benjamin Tranier as CEO (Designate), set to take the helm in March 2026, marking a strategic leadership transition aligned with its global expansion ambitions.

ARN Media announces a significant leadership change as CEO Ciaran Davis steps down after 16 years, with COO Michael Stephenson set to take the helm in January 2026.

Frontier Digital Ventures announces key leadership changes with Patrick Grove stepping in as Executive Chairman and a planned CEO transition by November 2025.

InVert Graphite has appointed Andrew Lawson as Managing Director following his initial CEO tenure, signaling confidence in his leadership as the company advances its critical minerals projects.

Proteomics International Laboratories announces the planned retirement of its founder and Managing Director, Dr Richard Lipscombe, in February 2026, marking a pivotal leadership transition as the company seeks a new CEO to drive its next growth phase.